Multiomics Market - Top Companies and Manufacturers

  • Report ID: 6091
  • Published Date: Nov 15, 2024
  • Report Format: PDF, PPT

Companies Dominating the Multiomics Landscape

    Important companies apply for product approvals in order to expand as a means of improving production and development efforts as well as to broaden the product's appeal and availability in a variety of geographic locations. Furthermore, a number of businesses are purchasing smaller competitors in an effort to improve their market share.

    • Becton, Dickinson and Company
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Thermo Fisher Scientific, Inc.
    • Illumina, Inc.
    • Danaher Corporation
    • PerkinElmer, Inc.
    • Bruker
    • Centogene N.V.
    • Element Biosciences
    • QIAGEN
    • Agilent Technologies, Inc.

Browse Key Market Insights with Data Illustration:

In the News

  • Element Biosciences, Inc., innovative scientific technology supplier announced a collaboration with Precision Health Data Cloud leader DNAnexus. Customers can now easily transfer data from Element's AVITITM System to their DNAnexus accounts thanks to this partnership. Customers can leverage a powerful combination of capabilities by combining the outstanding performance of AVITI sequencing with the safe and extensive multi-omic analysis platform offered by DNAnexus.
  • Centogene N.V. has announced the addition of cutting-edge transcriptome analysis to its MOx diagnostic portfolio. This single-step multi-omic system, called MOx 2.0, combines biochemical testing, DNA sequencing, and recently introduced RNA sequencing to provide healthcare practitioners with an unmatched depth of diagnostic capabilities.

Author Credits:  Radhika Pawar


  • Report ID: 6091
  • Published Date: Nov 15, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of multiomics is evaluated at USD 3.09 billion.

The multiomics market size was valued at USD 2.76 billion in 2024 and is set to exceed USD 17.17 billion by 2037, expanding at over 15.1% CAGR during the forecast period i.e., between 2025-2037. The market growth is due to growing need for targeted medicines and personalized medicine.

North America industry is likely to hold largest revenue share of 40% by 2037, influenced by presence of important players in the region.

The major players in the market are Thermo Fisher Scientific, Inc., Illumina, Inc., Danaher Corporation, PerkinElmer, Inc., Bruker, Centogene N.V., Element Biosciences, QIAGEN, Agilent Technologies, Inc., and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample